AI-generated research brief — verify at source
Novel OFM-HA Composite Dressing Nearly Doubles 12-Week Healing Rates in Diabetic Foot Ulcers
In a randomized controlled trial of 143 patients, adding a composite ovine forestomach matrix and hyaluronic acid product (OFM-HA) to standard of care resulted in wound closure in 46% of patients by 12 weeks, compared with 24% receiving standard of care alone (p = 0.008). While the absolute difference is clinically meaningful, the robustness of this finding is tempered by methodological concerns that introduce uncertainty about the true magnitude of the effect.
What Was Studied
This trial investigated whether OFM-HA — a novel cellular, acellular and matrix-like product (CAMP) combining ovine forestomach matrix with high molecular weight hyaluronic acid — could improve complete wound closure rates at 12 weeks when added to standard of care in patients with diabetes who have chronic, full-thickness foot wounds. The study addressed a recognized gap in treatment options for diabetic foot ulcers that fail to respond adequately to conventional wound management.
How It Was Studied
This was a prospective, multi-centre randomized controlled trial enrolling 143 adults with diabetes who had chronic full-thickness wounds of the foot meeting pre-specified eligibility criteria. Participants were randomly assigned to receive either OFM-HA in addition to standard of care or standard of care alone, and were followed for 12 weeks. The primary endpoint was the proportion of wounds achieving full closure by week 12. Secondary endpoints captured healing time, percentage area reduction, adverse events, and changes in patient-reported pain and quality of life. The modified intent-to-treat population served as the basis for the primary analysis.
What Was Observed
- Wound closure was nearly twice as frequent with OFM-HA plus standard of care: 46% of patients in the combination group (31 of 68) achieved full wound closure by 12 weeks, versus 24% (17 of 72) in the standard of care alone group. This difference was statistically significant (p = 0.008), representing a clinically meaningful absolute improvement of approximately 22 percentage points.
- Time-to-healing analysis also favoured OFM-HA: Kaplan-Meier survival analysis demonstrated a statistically significant advantage for the OFM-HA plus standard of care group over the 12-week observation period (log-rank p = 0.023), indicating that patients in the intervention arm reached wound closure more rapidly as well as more frequently.
- The adjusted comparison narrowed toward the significance threshold: When statistical adjustments were applied, the between-group difference remained significant but moved closer to conventional boundaries (adjusted p = 0.045), signalling that the effect size may be more modest than the unadjusted result suggests.
- No unexpected safety events were identified: The investigators reported no unanticipated adverse occurrences attributable to OFM-HA, suggesting an acceptable safety profile in this population over the 12-week period.
Why This Matters
Diabetic foot ulcers represent a severe complication of diabetes that substantially diminishes quality of life and imposes considerable healthcare costs, and current standard of care alone leaves a large proportion of wounds unhealed. This trial provides controlled evidence that OFM-HA may offer a meaningful improvement in healing rates for a population whose wounds have failed conventional management, supporting the potential role of advanced composite CAMPs in this difficult clinical setting. The trial also measured patient-reported outcomes including pain and quality of life, reflecting an attempt to capture the broader impact of treatment beyond wound closure alone.
How to Read This Result
Although the primary result is statistically significant and directionally positive, this is a moderately sized single trial whose interpretation is complicated by post-randomization exclusions, differential withdrawal, and an adjusted effect estimate that approaches rather than comfortably exceeds conventional significance thresholds — all of which argue for cautious interpretation and the need for confirmatory evidence before drawing firm conclusions.
Limitations
The authors explicitly acknowledge three factors that constrain interpretation: patients were excluded after randomization, withdrawal rates differed between the two arms, and the adjusted statistical comparison yielded a p-value of 0.045 — close enough to the conventional threshold of 0.05 that the finding cannot be considered robustly established. Taken together, these issues raise the possibility that the observed treatment effect could be somewhat overstated, and independent replication in larger, more rigorously controlled trials would be needed to confirm these findings.